TOXICOLOGICAL AND PHARMACOLOGICAL CHARACTERISTICS OF EXCIPIENTS OF DRUG PRODUCTS OF TORASEMIDE

TOXICOLOGICAL AND PHARMACOLOGICAL CHARACTERISTICS OF EXCIPIENTS OF DRUG PRODUCTS OF TORASEMIDE

Information on the toxicological and pharmacological characteristics of the main excipients used in the formulation of torasemide (sodium croscarmellose, microcrystalline cellulose, magnesium stearate, pregelatinized corn starch, silica, mannitol) is presented in the article.

Saved in:

Bibliographic Details
Main Authors:	D. Yu. Ivkin, A. A. Teslev, A. S. Dziuba, A. S. Ivkina
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	torasemide excipient generic safety toxicity pharmaceutical development
Online Access:	https://www.pharmjournal.ru/jour/article/view/544
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Interchangeability of Fluconazole Drugs
by: N. D. Bunyatyan, et al.
Published: (2018-12-01)

Biofunctional Excipients: Their Emerging Role in Overcoming the Inherent Poor Biopharmaceutical Characteristics of Drugs
by: Milad Reda Qelliny, et al.
Published: (2025-05-01)

The Use of Plant-Derived Biomaterials as Drug Formulation Excipients: An Application of Biomimetics in Dosage Form Development
by: Omobolanle Ayoyinka Omoteso, et al.
Published: (2024-05-01)

INFLUENCE OF TORASEMIDE ON ELECTRICAL INSTABILITY OF THE HEART IN PATIENTS WITH ISCHEMIC MITRAL REGURGITATION POST MYOCARDIAL INFARCTION
by: I. B. Ibragimova, et al.
Published: (2018-04-01)

Torasemide – loop diuretic with specific effects
by: V. M. Gorbunov, et al.
Published: (2006-10-01)

TORASEMIDE IN PREVENTION OF MITRAL REGURGITATION AND CHRONIC HEART FAILURE WORSENING IN POSTINFARCTION PERIOD
by: A. A. Abdullaev, et al.
Published: (2018-06-01)

Neonatal metabolic alkalosis and mild diuresis resulting from torasemide self-medication by the mother: a case report
by: Yumi Kitahiro, et al.
Published: (2025-04-01)

CLINICAL EFFICACY OF LOOP DIURETIC TORASEMIDE IN TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE. RESULTS OF KAZAKHSTAN MULTICENTER STUDY "POET"
by: S. F. Berkinbaev, et al.
Published: (2015-09-01)

EFFECT OF FUROSEMIDE AND TORASEMIDE ON HEART RATE VARIABILITY AND VENTRICULAR RHYTHM DISORDERS IN PATIENTS WITH CHRONIC HEART FAILURE COMPLICATING ISCHEMIC HEART DISEASE: COMPARATIVE NONRANDOMIZED STUDY
by: H. H. Shugushev, et al.
Published: (2016-01-01)

Study of the Influence of Pharmaceutical Excipients on the Solubility and Permeability of BCS Class II Drugs
by: Vivien Bárdos, et al.
Published: (2025-04-01)

Pharmacogenetics as a Way for Personalizing Diuretic Therapy: Focus on Torasemide
by: N. M. Gafurova, et al.
Published: (2021-03-01)

GELS FOR ORAL ADMINISTRATION. PART 2. EXCIPIENTS (REVIEW)
by: E. Y. Zagorulko, et al.
Published: (2019-01-01)

Effects of bisoprolol combined with torasemide on cardiac electrophysiology in patients with acute myocardial infarction and heart failure
by: Li Jing, et al.
Published: (2025-08-01)

Nifuroxazide Pharmaceutical Preparations in the Russian Federation. Publication One: Nomenclature, Chemical and Pharmaceutical Characteristics of the Preparations’ Composition
by: V. I. Kocherovets, et al.
Published: (2021-10-01)

Entecavir: stability and drug-excipient compatibility
by: Ariadne Botto Fiorot, et al.
Published: (2025-01-01)

EXCIPIENTS IN ORAL SUSPENSIONS
by: V. V. Vernikovsky, et al.
Published: (2019-01-01)

A review on the role of co-processed excipients in tablet formulations
by: Ankita S. Burande, et al.
Published: (2024-12-01)

Current Clinical and Pharmacological Approaches to the Prescription of Loop Diuretics in Patients with Chronic Heart Failure
by: N. M. Gafurova, et al.
Published: (2020-09-01)

Assessment of mandatory declaration excipients in pediatric off label prescriptions in Spain
by: Irene Lizano-Díez, et al.
Published: (2025-07-01)

Multifunctional investigation of “drug–excipient unification” of natural polysaccharide nanocarriers: A new paradigm from drug delivery to adjuvant therapy
by: Huan Yang, et al.
Published: (2025-09-01)

THE IMPORTANCE OF CHROMATOGRAPHICALLY PURIFIED EXCIPIENTS
by: G. J. Rizzo, et al.
Published: (2019-01-01)

Investigation of the effect of the excipients quantitative characteristics on the main indicators of ophthalmic/otologic suspension quality
by: I. V. Zavalko
Published: (2013-04-01)

Ranking mAb–excipient interactions in biologics formulations by NMR spectroscopy and computational approaches
by: Chunting Zhang, et al.
Published: (2023-12-01)

Defining Structure‐Function Relationships of Amphiphilic Excipients Enables Rational Design of Ultra‐Stable Biopharmaceuticals
by: Alexander N. Prossnitz, et al.
Published: (2025-02-01)

Influence of Excipients and Pressing Force on the Impurity Content of N-(4-aminobenzoyl)-L-glutamic Acid in Folic Acid Drugs During Storage
by: N. A. Obraztsova, et al.
Published: (2023-05-01)

Justification of the choice of excipients during the development of the composition of “Pastinocard” tablets
by: N. А. Symonenko, et al.
Published: (2023-11-01)

Excipients for Cerium Dioxide Nanoparticle Stabilization in the Perspective of Biomedical Applications
by: Svetlana A. Titova, et al.
Published: (2025-03-01)

Derivatografic study of the ointment with piroctone olamine for therapy and prevention of seborrheic dermatitis
by: V. A. Solodovnyk, et al.
Published: (2020-08-01)

Study of the technological properties of excipients in the development of the composition of orally dispersible tablets
by: I. D. Kasymov, et al.
Published: (2021-12-01)

Effects of the high-molecular excipients on optimization of the pharmacokinetic properties of drugs
by: P. . Bochkov, et al.
Published: (2020-04-01)

APPROACHES TO THE SELECTION OF EXCIPIENTS FOR DENTAL GEL WITH CETYLPYRIDINIUM CHLORIDE
by: E. Yu. Zagorulko, et al.
Published: (2021-06-01)

Original drugs and generics: are there any differences from the clinician’s point of view?
by: S. Yu. Martsevich, et al.
Published: (2024-10-01)

Influence of Ionization and the Addition of Cyclodextrins and Hydrophilic Excipients on the Solubility of Benzthiazide, Isoxicam, and Piroxicam
by: Diego Lucero-Borja, et al.
Published: (2025-04-01)

The choice of auxiliary substances to obtain sublingual glycin tablets with thiotriazoline with direct compaction method Reporting 1. Study of the influence of excipients on the bulk density, the bulk density after shrinkage, the fluidity and the angle o
by: L. I. Kucherenko, et al.
Published: (2020-05-01)

Investigation of excipients’ nature influence on the quality indices of effervescent tablets of acetylsalicylic acid, paracetamol and ascorbic acid
by: О. V. Tryhubchak, et al.
Published: (2018-03-01)

Development of Chitosan-Maize Starch based Co-processed excipient: As release retardant material
by: Smit Patel, et al.
Published: (2024-12-01)

Role and Safety of Excipients in Syrups (Review)
by: V. V. Kosenko, et al.
Published: (2025-05-01)

THE ANALYSIS OF THE PHARMACEUTICAL MARKET ON THE EXAMPLE OF MEDICINES OF GROUP OF INHIBITORS OF THE PROTON POMP
by: N. V. Mazova, et al.
Published: (2019-01-01)

CHARACTERIZATION AND PHARMACEUTICAL EVALUATION OF DAUCUS CAROTA PECTIN AS A SUSPENDING AGENT IN ORAL DOSAGE FORMS
by: Frederick William Akuffo Owusu, et al.
Published: (2024-03-01)

Observational study of clinical toxicity with different formulations of docetaxel in breast cancer patients
by: Eva González-Haba-Peña, et al.
Published: (2020-09-01)